The face of chronic migraine: epidemiology, demographics, and treatment strategies

Neurol Clin. 2009 May;27(2):467-79. doi: 10.1016/j.ncl.2009.01.001.

Abstract

Chronic daily headache (CDH) represents a therapeutic challenge for many clinicians. Treatment strategies should be aimed at correctly identifying the presence of CDH. In addition, an effective prophylactic regimen should be initiated; the presence of medication overuse must be addressed, and the offending medication being overused must be discontinued. Aside from analgesic overuse, other modifiable risk factors associated with the development of chronic migraine and CDH must be addressed including obesity and caffeine use and the effective management of comorbid conditions such as depression, anxiety, and sleep-related breathing disorders.

Publication types

  • Review

MeSH terms

  • Analgesics / therapeutic use*
  • Headache Disorders / diagnosis
  • Headache Disorders / drug therapy
  • Headache Disorders / epidemiology*
  • Headache Disorders / surgery
  • Headache Disorders / therapy*
  • Humans
  • Migraine Disorders / diagnosis
  • Migraine Disorders / drug therapy
  • Migraine Disorders / epidemiology*
  • Migraine Disorders / surgery
  • Migraine Disorders / therapy*
  • Nerve Block / methods
  • Serotonin Receptor Agonists / therapeutic use*
  • Treatment Outcome
  • Vagus Nerve Stimulation / methods

Substances

  • Analgesics
  • Serotonin Receptor Agonists